Indivior appoints Tony Kingsley to board; directors adopt equity purchase plan

Indivior Pharmaceuticals, Inc.

Appointed Tony Kingsley as independent non-executive director effective July 1, 2025.
Kingsley appointed per Oaktree relationship agreement; former CEO of Scholar Rock and Stablix.
Five US non-executive directors entered JP Morgan purchase plan; company funds ~70% of after-tax retainer into shares.
UK director Juliet Thompson bought 1,925 shares on June 11; company to reimburse over next year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.